Matrix Metalloproteinase‐9‐Responsive Surface Charge‐Reversible Nanocarrier to Enhance Endocytosis as Efficient Targeted Delivery System for Cancer Diagnosis and Therapy-Reference-Cited by-同舟云学术

Matrix Metalloproteinase‐9‐Responsive Surface Charge‐Reversible Nanocarrier to Enhance Endocytosis as Efficient Targeted Delivery System for Cancer Diagnosis and Therapy

Published:2021-03-10 Issue:9 Volume:10 Page:2002143
ISSN:2192-2640
Container-title:Advanced Healthcare Materials
language:en
Short-container-title:Adv. Healthcare Mater.

Author:

Han Qiu‐Ju¹,Lan Xiao‐Tong¹,Wen Ying¹,Zhang Chuan‐Zeng¹,Cleary Michael²,Sayyed Yasra¹,Huang Guangdong³,Tuo Xiaoling³,Yi Long⁴,Xi Zhen⁵,Li Lu‐Yuan¹,Zhang Qiang‐Zhe¹^ORCID

Affiliation:

1. State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy Tianjin Key Laboratory of Molecular Drug Research Nankai University Tianjin 300350 China

2. Laboratory Medicine Yale New Haven Hospital New Haven CT 06510 USA

3. Sino‐science Gene Technology Co., Ltd. Xi'an Shanxi 710018 China

4. State Key Laboratory of Organic‐Inorganic Composites and Beijing Key Laboratory of Energy Environmental Catalysis Beijing University of Chemical Technology (BUCT) 15 Beisanhuan East Road, Chaoyang District Beijing 100029 China

5. State Key Laboratory of Elemento‐Organic Chemistry National Engineering Research Center of Pesticide (Tianjin) Collaborative Innovation Center of Chemical Science and Engineering Nankai University Tianjin 300071 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adhm.202002143

Reference53 articles.

1. Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications

2. Cancer nanomedicine: progress, challenges and opportunities

3. Self-Assembled Nanomedicines for Anticancer and Antibacterial Applications